Research from Thomas Jefferson University Broadens Understanding of Headache (Real-world effectiveness of add-on fremanezumab in patients receiving onabotulinumtoxinA for the prevention of chronic migraine in a US tertiary headache center: A ...)

Press/Media

Period11 Apr 2024

Media coverage

1

Media coverage

  • TitleResearch from Thomas Jefferson University Broadens Understanding of Headache (Real-world effectiveness of add-on fremanezumab in patients receiving onabotulinumtoxinA for the prevention of chronic migraine in a US tertiary headache center: A ...)
    Media name/outletImmunotherapy Daily
    Country/TerritoryUnited States
    Date11/04/24
    PersonsFred Cohen